Detalles de la búsqueda
1.
Declining Risk of Sudden Death in Heart Failure.
N Engl J Med
; 377(1): 41-51, 2017 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28679089
2.
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
Eur Heart J
; 39(1): 26-35, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29040525
3.
Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).
Biomarkers
; 22(3-4): 261-267, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27325138
4.
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
Circulation
; 131(1): 43-53, 2015 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25406306
5.
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
Circulation
; 131(17): 1486-94; discussion 1494, 2015 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25810334
6.
Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial.
J Card Fail
; 21(2): 153-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25451704
7.
Predictive value of endostatin in chronic heart failure patients with poor kidney function.
Cardiology
; 130(1): 17-22, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25428583
8.
Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Eur Heart J
; 35(48): 3426-33, 2014 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25265976
9.
The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA).
BMC Med Genet
; 15: 140, 2014 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25528061
10.
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Eur Heart J
; 33(18): 2290-6, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22513778
11.
Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials.
PLoS Med
; 9(9): e1001310, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23028261
12.
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Am Heart J
; 164(6): 878-83, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23194488
13.
Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".
Circulation
; 132(22): e358, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26621661
14.
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
Circulation
; 120(22): 2188-96, 2009 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19917888
15.
Rosuvastatin in older patients with systolic heart failure.
N Engl J Med
; 357(22): 2248-61, 2007 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-17984166
16.
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
J Card Fail
; 15(4): 310-8, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19398079
17.
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.
Eur J Heart Fail
; 11(3): 281-91, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19168876
18.
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.
J Am Coll Cardiol
; 74(23): 2893-2904, 2019 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31806133
19.
Possible association between telomere length and renal dysfunction in patients with chronic heart failure.
Am J Cardiol
; 102(2): 207-10, 2008 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18602523
20.
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.
Eur J Heart Fail
; 20(5): 888-895, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29488676